Filing Details
- Accession Number:
- 0001140361-10-051707
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-30 17:46:55
- Reporting Period:
- 2010-12-28
- Filing Date:
- 2010-12-30
- Accepted Time:
- 2010-12-30 17:46:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 943819 | Resmed Inc | RMD | Surgical & Medical Instruments & Apparatus (3841) | 980152841 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1186102 | C Peter Farrell | Resmed Inc. 9001 Spectrum Center Boulevard San Diego CA 92123 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Common Stock | Disposition | 2010-12-28 | 138,962 | $0.00 | 533,230 | No | 4 | G | Direct | |
| Resmed Common Stock | Disposition | 2010-12-29 | 61,038 | $35.04 | 0 | No | 4 | S | Indirect | Peter C. Farrell December 2009 Annuity Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | G | Direct | |
| No | 4 | S | Indirect | Peter C. Farrell December 2009 Annuity Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Resmed Common Stock | 200,000 | Indirect | Peter C. Farrell April 2010 Annuity Trust |
| Resmed Common Stock | 200,000 | Indirect | Peter C. Farrell July 2010 Annuity Trust |
Footnotes
- Trade executed pursuant to 10b5-1 trading plan.
- Transaction represents a distribution from the Peter C. Farrell December 2009 Annuity Trust (the "Trust") of 138,962 shares to the Peter C. Farrell Family Trust (of which Dr. Farrell is the Trustee). Per the terms of the trust, 90% of the original value was transferred to Dr. Farrell at the end of the first year.
- Transaction represents the sale of the remaining shares in the Trust for cash, which was retained by the Trust.
- The price reported is the weighted average price. The shares were acquired in multiple transactions at prices ranging from $34.95 to $35.43, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
